https://www.msn.com/en-us/health/other/emory-doctor-hopeful-about-clinical-trial-for-new-skin-cancer-treatment/ar-BB1oTdCU?ocid=BingNewsVerp

Xcurespodcast

Alpha Tau delivers powerful radiation directly to tumors for treatment that is both more effective and gentler.

And now for something a bit different! Our Chief Medical Officer, Dr. Robert Den, MD, a renowned authority when it comes to cancer, was...

JERUSALEM, Sept. 14, 2023 -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the...

– Treated the first patient with advanced inoperable pancreatic cancer in a safety and feasibility trial in Canada in April – – 89% CR,...

JERUSALEM, August 24, 2023 -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the...

- 81 lesions treated across four feasibility trials of head and neck or skin cancers demonstrated 89% complete response rate. - Two-year...

JERUSALEM, August 02, 2023 -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the...

-First patient treated in the feasibility and safety study of intratumoral diffusing alpha radiation emitters for the treatment of...